Skip to main content

Haemodynamic Basis for Coronary Pharmacology

  • Chapter
  • 71 Accesses

Abstract

It would appear expedient, in opening this chapter, to anticipate the objection in a very general sense that drugs which increase coronary blood flow in animals are unsuited, for morphological reasons, to exerting their action on a sclerosed coronary system in a human being.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1971 Springer-Verlag/Berlin · Heidelberg

About this chapter

Cite this chapter

Charlier, R. (1971). Haemodynamic Basis for Coronary Pharmacology. In: Antianginal Drugs. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 31. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65165-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-65165-6_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-65167-0

  • Online ISBN: 978-3-642-65165-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics